Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 51 to 75 of 2013

TitleReference numberPublishedLast updated
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertensionHTG741
Alcohol-use disorders: diagnosis and management of physical complicationsCG100
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependenceCG115
Alcohol-use disorders: preventionPH24
Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancerTA1014
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)TA438
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosisTA312
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemiaTA393
Alitretinoin for the treatment of severe chronic hand eczemaTA177
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitusHTG165
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Alpha-Stim AID for anxiety disordersHTG570
Alteplase for treating acute ischaemic strokeTA264
Amantadine, oseltamivir and zanamivir for the treatment of influenzaTA168
Ambu aScope4 Broncho for use in unexpected difficult airwaysHTG312
Ambulight PDT for the treatment of non-melanoma skin cancerHTG268
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancerTA1122
Anakinra for treating Still's diseaseTA685
Anaphylaxis: assessment and referral after emergency treatmentCG134
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)TA1029
Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunctionHTG402
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859

Results per page

  1. 10
  2. 25
  3. 50
  4. All